Monopoly Rights for Cyproheptadine Tricholine Syrup

High Turnover: Guaranteed Sales Volume

Cyproslab T Edge: Top Doctor-Prescribed Appetizer

Secure Exclusive Territory in General/Pediatric Segment

Low Investment, Full Marketing Material Support
Launch Your High-Margin Syrup Business Today

Home/Products /cyproheptadine-hcl-i-p-2-mg-tricholine-citrate-i-p-275-mg-syrup

About the Product

Description


Cyproslab T Syrup (Cyproheptadine 2mg + Tricholine Citrate 275mg) is a high-turnover, high-profit product built for our PCD Pharma Franchise partners.

This established combination is essential for improving appetite, promoting weight gain, and supporting liver function (Tricholine Citrate). This guarantees strong, persistent demand across both the pediatric and general physician segments.

Why Cyproslab T is Your Key to Profit:

  1. High Volume, Consistent Demand: As a widely prescribed appetite stimulant and liver tonic, this product ensures rapid restocking cycles and consistently high sales volume throughout the year.

  2. Excellent Profit Margins: Positioned in a high-demand therapeutic segment, the product allows for competitive pricing while securing superior profit margins on every unit sold.

  3. Doctor Loyalty: The established, reliable composition builds immediate prescription trust from pediatricians and general practitioners, securing your long-term repeat orders.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated territory. Partner with us for full marketing support and timely supply to turn this essential, fast-moving product into guaranteed business growth.

Contact us today to secure this high-turnover syrup segment!

Patients may experience injection site discomfort, gastrointestinal upset (nausea, vomiting, diarrhea), rash, or mild liver enzyme elevations. Less commonly, hypersensitivity reactions and hematologic abnormalities such as eosinophilia or neutropenia may occur. Rare instances of C. difficile-associated diarrhea should be considered during prolonged use.

This formulation is used in the treatment of severe systemic infections such as urinary tract infections, lower respiratory tract infections (including pneumonia), intra-abdominal infections, skin and soft tissue infections, gynecological infections, and septicemia caused by susceptible gram-negative bacteria. It is particularly valuable in hospital-acquired infections or polymicrobial infections when used in combination with other antimicrobials.

This injection should only be used under the supervision of a qualified healthcare professional. Renal function should be monitored in long-term or high-dose treatments, and dose adjustment may be required in renal impairment. Aztreonam is not effective against gram-positive or anaerobic organisms, and should be used in combination therapy if mixed infections are suspected.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Cyproheptadine HCl I.P. 2mg + Tricholine Citrate I.P. 275mg Syrup in the PCD pharma franchise market?

This combination has strong demand in appetite stimulant and liver support segments, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include this syrup in their product range?

Medical distributors and wholesalers can benefit from consistent demand in pediatric appetite loss, undernutrition support, and digestive/liver function improvement therapy. It strengthens their general medicine and pediatric portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this syrup formulation?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Cyproheptadine HCl I.P. 2mg + Tricholine Citrate I.P. 275mg Syrup with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this syrup?

Wholesalers and medical agencies benefit from steady prescription demand, fast-moving appetite stimulant category sales, and good margins when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this syrup?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this appetite stimulant syrup can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.